NNVC Stock: NanoViricides, Inc. Stock Price, Analysis & Insights
Get live nnvc stock price $1.46, comprehensive NanoViricides, Inc. stock analysis, charts, news, and expert forecast. Real-time nnvc stock data and investment insights.
Company Overview
NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction; HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide. In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.
Company Information
- CEO
- Anil R. Diwan
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 7
Contact Information
- Address
- 1 Controls Drive
- Country
- US
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 23.38M market capitalization
- Trading Volume: 121.35K shares traded today
- Price Range: 52-week range of $0.94 - $1.92
- Exchange: Listed on New York Stock Exchange Arca
Financial Metrics
Market Analysis for NanoViricides, Inc.
NanoViricides, Inc. (NNVC) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 23.38M, the company represents a significant player in its market. The stock is currently trading at $1.46 with a positivedaily change of 0.34%.
The company's 7 employee base and presence on the New York Stock Exchange Arcaexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -2.11, beta of 1.15, and 52-week price range from $0.94 to $1.92when evaluating investment opportunities.
Why Invest in NanoViricides, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange Arca)
- • Experienced leadership under Anil R. Diwan
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.